{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:45:08Z","timestamp":1790163908556,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473256"],"award-info":[{"award-number":["81473256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273561"],"award-info":[{"award-number":["81273561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-1-014"],"award-info":[{"award-number":["2016-I2M-1-014"]}]},{"name":"Science and Technology Program of Beijing","award":["Z151100000115008"],"award-info":[{"award-number":["Z151100000115008"]}]},{"name":"Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation","award":["BZ0150"],"award-info":[{"award-number":["BZ0150"]}]},{"name":"Drug Innovation Major","award":["2015ZX09102-023"],"award-info":[{"award-number":["2015ZX09102-023"]}]},{"name":"Drug Innovation Major","award":["2018ZX09711001-003-002"],"award-info":[{"award-number":["2018ZX09711001-003-002"]}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["IER-143487"],"award-info":[{"award-number":["IER-143487"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.antiviral.2019.03.014","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T11:59:31Z","timestamp":1554379171000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Identification of a clinical compound losmapimod that blocks Lassa virus entry"],"prefix":"10.1016","volume":"167","author":[{"given":"Xiaoyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Banadyga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-9999","authenticated-orcid":false,"given":"Xiangguo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.03.014_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00574-17","article-title":"Mutational analysis of Lassa virus glycoprotein highlights regions required for alpha-dystroglycan utilization","volume":"91","author":"Acciani","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.03.014_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02063-14","article-title":"Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization","volume":"5","author":"Bederka","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.03.014_bib4","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2012.10.038","article-title":"The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain","volume":"436","author":"Burri","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.03.014_bib6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.03.014_bib7","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1038\/s41598-017-10198-0","article-title":"Determining Ribavirin's mechanism of action against Lassa virus infection","volume":"7","author":"Carrillo-Bustamante","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.03.014_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.apsb.2017.08.003","article-title":"Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors","volume":"8","author":"Chen","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.antiviral.2019.03.014_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molmed.2016.09.006","article-title":"Drug repurposing: new treatments for Zika virus infection?","volume":"22","author":"Cheng","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2019.03.014_bib10","series-title":"Biosafety in Microbiological and Biomedical Laboratories","first-page":"246","year":"2010"},{"key":"10.1016\/j.antiviral.2019.03.014_bib11","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.03.014_bib12","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/mp200641e","article-title":"Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction","volume":"9","author":"Funk","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2019.03.014_bib13","doi-asserted-by":"crossref","first-page":"j2986","DOI":"10.1136\/bmj.j2986","article-title":"Lassa fever","volume":"358","author":"Houlihan","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2019.03.014_bib14","doi-asserted-by":"crossref","first-page":"19967","DOI":"10.1073\/pnas.1108910108","article-title":"X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation","volume":"108","author":"Igonet","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.03.014_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.1252480","article-title":"Virus entry. Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.03.014_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.03.014_bib17","series-title":"Fields Virology","author":"Knipe","year":"2013"},{"key":"10.1016\/j.antiviral.2019.03.014_bib18","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.03.014_bib19","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.03.014_bib21","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/JVI.07241-11","article-title":"Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion","volume":"86","author":"Messina","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib22","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1128\/JVI.01587-15","article-title":"Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication","volume":"89","author":"Ngo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib23","series-title":"An Update of Lassa Fever Outbreak in Nigeria","year":"2019"},{"key":"10.1016\/j.antiviral.2019.03.014_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/13543784.2015.1006358","article-title":"Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease","volume":"24","author":"Norman","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2019.03.014_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jiv522","article-title":"Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever","volume":"213","author":"Oestereich","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.03.014_bib26","first-page":"V","article-title":"Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses. Introduction","volume":"262","author":"Oldstone","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib27","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1128\/JVI.00257-16","article-title":"Lassa virus cell entry via dystroglycan involves an unusual pathway of macropinocytosis","volume":"90","author":"Oppliger","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib28","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00705-015-2418-y","article-title":"Past, present, and future of arenavirus taxonomy","volume":"160","author":"Radoshitzky","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.10.002","article-title":"NRP2 and CD63 are host factors for Lujo virus cell entry","volume":"22","author":"Raaben","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.03.014_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib31","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.03.014_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-virology-101416-042001","article-title":"New World arenavirus biology","volume":"4","author":"Sarute","year":"2017","journal-title":"Ann. Rev. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fcell.2016.00091","article-title":"Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway","volume":"4","author":"Segales","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib34","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/JVI.00597-16","article-title":"Small-molecule fusion inhibitors bind the pH-sensing SSP-GP2 subunit interface of the Lassa virus envelope glycoprotein","volume":"90","author":"Shankar","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib35","doi-asserted-by":"crossref","DOI":"10.3791\/53124","article-title":"Early viral entry assays for the identification and evaluation of antiviral compounds","author":"Tai","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.antiviral.2019.03.014_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2018.10.011","article-title":"Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever","volume":"160","author":"Tang","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.03.014_bib37","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1128\/JVI.00512-14","article-title":"Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus","volume":"88","author":"Tani","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib38","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1074\/jbc.M110.196428","article-title":"A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junin hemorrhagic fever arenavirus","volume":"286","author":"Thomas","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.03.014_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00954-18","article-title":"Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.03.014_bib40","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S147276","article-title":"Current research for a vaccine against Lassa hemorrhagic fever virus","volume":"12","author":"Warner","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.antiviral.2019.03.014_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.antiviral.2019.03.014_bib42","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1128\/JVI.01140-08","article-title":"pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors","volume":"82","author":"York","year":"2008","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2019.03.014_bib43","first-page":"735","article-title":"Establishment of a cell-based evaluation system for arenavirus entry inhibitor","volume":"53","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:25Z","timestamp":1759062505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218307800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"alternative-id":["S0166354218307800"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.03.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a clinical compound losmapimod that blocks Lassa virus entry","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}